Repurposing of Kinase Inhibitors for Treatment of COVID-19

The outbreak of COVID-19, the pandemic disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spurred an intense search for treatments by the scientific community. In the absence of a vaccine, the goal is to target the viral life cycle and alleviate the lung-damaging...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pharm Res
Auteurs principaux: Weisberg, Ellen, Parent, Alexander, Yang, Priscilla L., Sattler, Martin, Liu, Qingsong, Liu, Qingwang, Wang, Jinhua, Meng, Chengcheng, Buhrlage, Sara J., Gray, Nathanael, Griffin, James D.
Format: Artigo
Langue:Inglês
Publié: Springer US 2020
Sujets:
Expert Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7417114/
https://ncbi.nlm.nih.gov/pubmed/32778962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-020-02851-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires